Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.
Tong
C Y William
CY
Mullen
Jane E
JE
Wong
Terry
T
D000328:Adult; D000595:Amino Acid Sequence; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D024882:Drug Resistance, Viral; D006147:Guanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology*; D008297:Male; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D012641:Selection, Genetic; D016896:Treatment Outcome
D000998:Antiviral Agents; D019259:Lamivudine; C413685:entecavir; D006147:Guanine